Cargando…

Modelling Cost-Effectiveness of Biologic Treatments Based on Disease Activity Scores for the Management of Rheumatoid Arthritis in Spain

Background. The objective of this simulation model was to assess the cost-effectiveness of different biological treatment strategies based on levels of disease activity in Spain, in patients with moderate to severe active RA and an insufficient response to at least one anti-TNF agent. Methods. Clini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beresniak, Ariel, Ariza-Ariza, Rafael, Garcia-Llorente, Jose Francisco, Ramirez-Arellano, Antonio, Dupont, Danielle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE-Hindawi Access to Research 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139138/ https://www.ncbi.nlm.nih.gov/pubmed/21785694 http://dx.doi.org/10.4061/2011/727634

Ejemplares similares

Cost-Effectiveness Modelling of Sequential Biologic Strategies for the Treatment of Moderate to Severe Rheumatoid Arthritis in Finland
por: Puolakka, K, et al.
Publicado: (2012)

The prevalence of rheumatoid arthritis in Spain
por: Silva-Fernández, Lucía, et al.
Publicado: (2020)

Poncet's disease mimicking rheumatoid arthritis in a patient with suspected Crohn's disease
por: Ariza‐Prota, Miguel, et al.
Publicado: (2015)

Experience With the Use of Rituximab for the Treatment of Rheumatoid Arthritis in a Tertiary Hospital in Spain: RITAR Study
por: Cañamares, Iciar, et al.
Publicado: (2019)

Administration costs of intravenous biologic drugs for rheumatoid arthritis
por: Soini, Erkki J, et al.
Publicado: (2013)

Economic burden of Cardiac Arrest in Spain: analyzing healthcare costs drivers and treatment strategies cost-effectiveness
por: Matilla-García, Mariano, et al.
Publicado: (2023)

Cost-effectiveness analysis of treatment sequences containing tofacitinib for the treatment of rheumatoid arthritis in Spain
por: Navarro, F., et al.
Publicado: (2020)

Cost-effectiveness analysis of baricitinib versus adalimumab for the treatment of moderate-to-severe rheumatoid arthritis in Spain
por: Schlueter, Max, et al.
Publicado: (2019)

Adherence to Treatment in Patients with Rheumatoid Arthritis from Spain
por: Pombo-Suarez, Manuel, et al.
Publicado: (2021)

The Cost-Effectiveness of Biologics for the Treatment of Rheumatoid Arthritis: A Systematic Review
por: Joensuu, Jaana T., et al.
Publicado: (2015)

Quality of Life and Cost Study of Rheumatoid Arthritis Therapy With Biological Medicines
por: Boyadzieva, Vladimira V., et al.
Publicado: (2018)

Pharmacoeconomic evaluation of costs of rheumatoid arthritis therapy with selected biological treatment
por: Kowalik, Krzysztof, et al.
Publicado: (2018)

Indirect costs of rheumatoid arthritis
por: Raciborski, Filip, et al.
Publicado: (2015)

Improving Performance of Clinical Research: Development and Interest of Electronic Health Records
por: Beresniak, Ariel, et al.
Publicado: (2015)

A survey of Mycoplasma agalactiae in dairy sheep farms in Spain
por: Ariza-Miguel, Jaime, et al.
Publicado: (2012)

Cost-effectiveness modelling of use of urea breath test for the management of Helicobacter pylori-related dyspepsia and peptic ulcer in the UK
por: Pritchard, D. Mark, et al.
Publicado: (2021)

Cardiovascular risk score in Rheumatoid Arthritis
por: Wagan, Abrar Ahmed, et al.
Publicado: (2016)

Osteoporosis in Rheumatoid Arthritis: Dangerous Liaisons
por: Llorente, Irene, et al.
Publicado: (2020)

Streptococcus suis Infection and Malignancy in Man, Spain
por: Gómez-Zorrilla, Silvia, et al.
Publicado: (2014)

Cost per response for abatacept versus adalimumab in rheumatoid arthritis by ACPA subgroups in Germany, Italy, Spain, US and Canada
por: Weijers, Laure, et al.
Publicado: (2017)

The FLURESP European commission project: cost-effectiveness assessment of ten public health measures against influenza in Italy: is there an interest in COVID-19 pandemic?
por: Beresniak, Ariel, et al.
Publicado: (2023)

Incretin Therapy for Type 2 Diabetes in Spain: A Cost-Effectiveness Analysis of Liraglutide Versus Sitagliptin
por: Mezquita Raya, Pedro, et al.
Publicado: (2013)

Treatment Persistence and Healthcare Costs Among Patients with Rheumatoid Arthritis Changing Biologics in the USA
por: Chastek, Benjamin, et al.
Publicado: (2017)

REDOSER project: optimising biological therapy dose for rheumatoid arthritis and spondyloarthritis patients
por: González-Álvaro, Isidoro, et al.
Publicado: (2017)

Hospitalization burden and comorbidities of patients with rheumatoid arthritis in Spain during the period 2002–2017
por: Gil-Conesa, Mario, et al.
Publicado: (2020)

Exceptional coprolite association from the Early Cretaceous continental Lagerstätte of Las Hoyas, Cuenca, Spain
por: Barrios-de Pedro, Sandra, et al.
Publicado: (2018)

Biologic monotherapy in the treatment of rheumatoid arthritis
por: Detert, Jacqueline, et al.
Publicado: (2015)

Biologicals in rheumatoid arthritis: current and future
por: Avci, Ali Berkant, et al.
Publicado: (2015)

Treatment with Biologicals in Rheumatoid Arthritis: An Overview
por: Rein, Philipp, et al.
Publicado: (2017)

Dataset on unmanned aerial vehicle multispectral images acquired over a vineyard affected by Botrytis cinerea in northern Spain
por: Vélez, Sergio, et al.
Publicado: (2023)

Biologic refractory disease in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
por: Kearsley-Fleet, Lianne, et al.
Publicado: (2018)

Cost-utility analysis of certolizumab pegol versus alternative tumour necrosis factor inhibitors available for the treatment of moderate-to-severe active rheumatoid arthritis in Spain
por: Hidalgo-Vega, Álvaro, et al.
Publicado: (2015)

Cost-effectiveness of adalimumab for rheumatoid arthritis in Germany
por: Gissel, C., et al.
Publicado: (2016)

Analysis of the Indirect Costs of Rheumatoid Arthritis in Romania
por: Codreanu, Cătălin, et al.
Publicado: (2019)

Cost-Effectiveness Analysis of Incretin Therapy for Type 2 Diabetes in Spain: 1.8 mg Liraglutide Versus Sitagliptin
por: Pérez, Antonio, et al.
Publicado: (2015)

VineLiDAR: High-resolution UAV-LiDAR vineyard dataset acquired over two years in northern Spain
por: Vélez, Sergio, et al.
Publicado: (2023)

Biologic Agents in Rheumatoid Arthritis: An Update for Managed Care Professionals
por: Agarwal, Sandeep K.
Publicado: (2011)

Dual Biologic Therapy in Patients with Rheumatoid Arthritis and Psoriatic Arthritis
por: Furer, Victoria, et al.
Publicado: (2023)

Comparison of Healthcare Costs Between Rheumatoid Arthritis Patients Treated with Infused Biologics After Switching from Another Biologic
por: Johnston, Stephen S., et al.
Publicado: (2015)

Application of a validated algorithm to estimate the effectiveness and cost of biologics for rheumatoid arthritis in the US pharmacy benefit manager context
por: Wu, Ning, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0ojegmkqeld8s0hqpf9uhnd8kp